Weekly Recap | PICC GROUP -2.56%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.PICC GROUP (1339.HK) fell 2.56% this week to close at HK$5.90, underperforming the Hang Seng Index by about 0.17 percentage points. The stock traded in a choppy range: Monday (9 Sep) opened at HK$6.025, touched HK$6.085 intraday, then slipped to close at HK$5.90; Tuesday (9 Sep) gapped down to a low of HK$5.81 before closing at HK$5.855; Wednesday (9 Sep) briefly recovered to HK$5.965 and closed at HK$5.945; Thursday (10 Sep) pulled back again to end at HK$5.90. The weekly range was 4.
The Week
PICC GROUP (1339.HK) fell 2.56% this week to close at HK$5.90, underperforming the Hang Seng Index by about 0.17 percentage points. The stock traded in a choppy range: Monday (9 Sep) opened at HK$6.025, touched HK$6.085 intraday, then slipped to close at HK$5.90; Tuesday (9 Sep) gapped down to a low of HK$5.81 before closing at HK$5.855; Wednesday (9 Sep) briefly recovered to HK$5.965 and closed at HK$5.945; Thursday (10 Sep) pulled back again to end at HK$5.90. The weekly range was 4.9%, and average daily volume of 41.7m shares ran 26.1% above the 60-day median.
Key Events
This week’s story centred on the Ministry of Finance’s capital injection into state-owned insurers. On 7 Sep, Citi said the MoF had trimmed the insurer capital injection to RMB60b, positive for PICC GROUP H shares and China Re; the same day, BofA Securities said the capital increase carried limited shareholder dilution, reiterating a Buy with a HK$7.8 target price, while Morgan Stanley called it neutral and focused on execution details. On 8 Sep, Huatai Securities noted PICC would receive RMB15b via a private placement from the MoF, maintaining Buy; Goldman Sachs said the central capital injection signalled sector support and reiterated Buy. On 10 Sep, the company published notices covering a general share issuance mandate, a private placement of A shares, the election of Ms Yang Dongning as executive director, interim dividend distribution for 2026, and the second EGM of 2026.
Analyst Ratings
Among 12 brokers covering the stock, 6 rate it Buy, 3 Overweight and 3 Hold; none rate it Underweight or Sell. The consensus recommendation is Buy, with a consensus target price of HK$7.39, about 25.2% above the latest close. Target prices range from HK$5.875 to HK$9.077, showing wide dispersion. The stock ranks second among two names in the property and casualty insurance industry.
The Week Ahead
Hong Kong will report its unemployment rate, with the prior reading at 3.7%, and on 23 Sep the composite CPI figure is due, with a prior reading of 1.7%. Company-wise, the EGM on 29 Sep will vote on the interim profit distribution, the A-share issuance, and Ms Yang Dongning’s appointment as executive director; the interim dividend update was already published on 10 Sep.
In Short
Most brokers rate the stock Buy and the consensus target sits above spot, while valuation is modest at about 3.98x P/E and 0.66x P/B, yet the share price still lagged the market this week. On the latest trading day, large-lot orders were net buyers by 261.41, medium orders by 1506.13, while small orders were net sellers by 870.57. Dilution worries from the capital injection and A-share issuance sit alongside policy support signals, so the near-term focus falls on the EGM vote and how the interim dividend is delivered.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
